ThursdayFeb 10, 2011 12:35 pm

NeoGenomics (NGNM.OB) Posts Financial Results for Difficult Q4 and FY2010, Optimistic of Future

NeoGenomics Inc., a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter 2010 and fiscal year ended December 31, 2010. Douglas VanOort, chairman and CEO, noted difficult times for the company, as well as positive achievements. "We experienced many headwinds in 2010 that impacted our revenue growth and our profitability. Despite these headwinds, we grew our core revenue faster than many in our laboratory peer group,” VanOort stated in the press release. “In addition, the quality of our service to clients is outstanding and our recent cost cutting initiatives and productivity enhancements are starting…

Continue Reading

ThursdayFeb 10, 2011 12:33 pm

RF Micro Devices Inc. (RFMD) to Showcase its Innovative RF Technologies at 2011 Mobile World Congress in Barcelona

RF Micro Devices Inc., a global leading designer and manufacturer of high-performance radio frequency components and compound semiconductor technologies, today announced it will present a broad selection of industry-leading radio frequency (RF) components for the global mobile device market at the 2011 Mobile World Congress (MWC) in Barcelona, Spain, from February 14 to February 17, 2011. RFMD’s portfolio consists of innovative RF component, including cell tower amplifier modules, cellular transmit modules, and front ends for Wi-Fi, WiMAX and GPS applications, among others. It is also expanding its portfolio to include wireless infrastructure products. For the MWC, the company will highlight…

Continue Reading

ThursdayFeb 10, 2011 11:42 am

Have You Met the QualityStocks Team Yet?

QualityStocks is comprised of a group of individuals all dedicated to connecting investors with companies that have huge potential to succeed in the short and long term future. Each one brings a special talent to the site, whether it be video production, advertising and sales, graphic and design, or writing expertise. When QualityStocks was started several years ago, it was just an idea for a Small Cap Newsletter that started with only 150 friends and family e-mail addresses. Today, it is a multi-million dollar brand and its rapid success is credited to the team who has helped re-shape the small…

Continue Reading

ThursdayFeb 10, 2011 11:38 am

Lotus Pharmaceuticals, Inc. (LTUS.OB) is “One to Watch”

Lotus Pharmaceuticals, Inc. develops, manufactures and distributes pharmaceutical products in the People’s Republic of China. A rapidly growing company, Lotus is focused on developing new products that address their customers’ real needs. The company manufactures branded drugs and distributes them along with products produced by third-party manufacturers. The Chinese government has increased overall spending on healthcare in recent years, and improving rural healthcare is a national priority. The pharmaceuticals market in China is expected to expand twice as fast as the global pharmaceuticals market. In addition to a favorable political and regulatory environment, this growth is driven by rising incomes…

Continue Reading

ThursdayFeb 10, 2011 11:21 am

QualityStocks Attends The World MoneyShow in Orland

Today is the second day of The World MoneyShow Conference taking place in Orlando, FL at the Gaylord Palms Hotel & Convention Center. Attendees have had the chance to meet face to face with top investment and trading experts as well as network with other investors to share ideas. They've also had the opportunity to discover and compare investment products and services in the Exhibit Hall. As the name implies, the conference has a global focus, with emphasis on protecting assets, maximizing gains and learning from expert advice. The MoneyShow was able to secure a stellar speaker roster of more…

Continue Reading

ThursdayFeb 10, 2011 10:45 am

Caliper Life Sciences Inc. (CALP) Optical Imaging System Sales Surpass 1,000 Units

Caliper Life Sciences Inc. is a leading provider of cutting-edge technologies enabling researchers in the life sciences field to create medicines and diagnostic tests more quickly and efficiently. The company's portfolio of products include state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies and discovery & development outsourcing solutions. The company announced today it has installed the 1000th IVIS preclinical imaging system, a milestone event in the rapid adoption of Caliper's proprietary in vivo imaging solutions. The center for Advanced Molecular Imaging at Northwestern University purchased Caliper's IVIS Spectrum to enable nano-particle technology research for the targeting of cancer…

Continue Reading

ThursdayFeb 10, 2011 10:02 am

Five Chart Patterns Every Investor Should Know

Investors analyze chart patterns to make both short-term or long-term forecasts. The data can be compiled intraday, daily, weekly or monthly and the patterns can be as short as one day or as long as multiple years. Below we will look at a few both new and experienced investors can learn from. Head and ShouldersThe Head and Shoulders chart pattern is known for its reliably in predicting a reversal in trend. There are two versions of the head-and-shoulders pattern: the kind that forms at the top of a run and the type that signals a downtrend is over (known as…

Continue Reading

ThursdayFeb 10, 2011 8:57 am

Max Media Group, Inc. (MXMI.PK) Completes Acquisition of Members Autolink

Today before the opening bell, Max Media Group, Inc. announced that it closed the acquisition of Members Autolink (http://www.membersautolink.com), a car buying service working with eight Tampa Bay area credit unions that collectively serve more than 350,000 members. James Grady President & CEO of Max Media Group, Inc. commented, "This is a very exciting acquisition for us. We have been looking for an opportunity to get into the 'every day car market.' Autolink will do this in a big way very quickly and add instant revenue to Max Media. The unique way that Autolink combines car dealer inventory and the…

Continue Reading

ThursdayFeb 10, 2011 8:53 am

Oncothyreon Inc. (ONTY) Secures $12.5M Loan to Support Phase II Trials and Operations through 2012

Oncothyreon Inc., a biotechnology company focused on the development of innovative therapeutic products for the treatment of cancer, yesterday announced it has entered into an aggregate $12.5 million secured loan facility from GE Capital, Healthcare Financial Services. The initial term loan was for $5.0 million, which was funded February 8, 2011. Oncothyreon has the option to draw the remaining $7.5 million any time before November 1, 2011, subject to the achievement of certain clinical milestones and other customary conditions. The company said it will use the funds to support clinical development activities, focusing on the phase II trials of PX-866,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered